NY-EMPIRE-STATE-REALTY
30.1.2024 21:15:26 CET | Business Wire | Press release
Celebrate the most romantic day of the year at the “World’s Most Romantic Building.” The Empire State Building (ESB) – the number one attraction in the U.S. by Tripadvisor travelers for two consecutive years – announced today that it will host themed movie screenings; offer an over-the-top, bucket list Valentine’s Day date for one lucky couple; and provide a special engagement package for couples who plan to tie the knot this February.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240130140269/en/
‘World’s Most Romantic Building:’ Empire State Building Celebrates Valentine’s Day with NYC's Most Romantic Date Experience, Engagement Package, and Film Screenings (Photo: Business Wire)
- Empire for Two – This year, one lucky couple can book the Empire State Building’s first ever private Valentine’s Day dining experience, that for a $10k price tag gives them access to the entire 86th Floor Observatory all to themselves, as well as a three-course dinner with wine pairing high atop the exclusive 102nd Floor, that is also closed for the entirety of the date. Curated and prepared by the head chef at STATE Grill and Bar – the Empire State Building’s signature restaurant on ground level – dishes include options like lump crab with caviar, porcini crusted filet mignon, and a decadent chocolate cake, accompanied by a live musician and themed decor. Before dinner, the couple will embark on a private tour of the Empire State Building with Champagne. The lavish Empire for Two ticket package is available for Feb. 14 at 8:30 p.m. and must be reserved by Feb. 12.
- “As IF!” – Gather your girlfriends this Galentine’s Day for a one-time screening of the quotable comedy “Clueless” on the Empire State Building Observatory’s 80th Floor on Feb. 13. Fans will enjoy drinks and snacks from Culture POP, Dylan’s Candy Bar, and Rob’s Backstage Popcorn included with their ticket. Mixologists will shake up complimentary espresso martinis – courtesy of the newly opened, 23,000 square foot Starbucks Reserve® located at the base of the building – for guests to sip on with the movie before they take in the views from the 86th and 102nd Floor Observatories.
- “It’s a Sign” – Channel the romance of “Sleepless in Seattle” – the classic ‘90s love story that features scenes filmed at the “World’s Most Romantic Building” – in a special screening on Feb 14. Guests will enjoy the film screening on the building’s 80th Floor with complimentary drinks and snacks from Culture POP, Dylan’s Candy Bar, Rob’s Backstage Popcorn included with their ticket. In a nod to their deep Seattle heritage, Starbucks Reserve® will serve complimentary espresso martinis to guests before they recreate the movie magic on the 86th and 102nd Floor Observatories.
- Happily Ever Empire – Toast to forever with ESB’s exclusive engagement experience this February. The Happily Ever Empire package includes an exclusive guided tour of the Observatory Experience; a private, roped-off corner of the 86th Floor Observatory to pop the question; and a bottle of Champagne to toast to your “yes!”
- Love Lights – On Feb. 14, the Empire State Building’s world-famous tower lights will shine in a pink heartbeat in its annual Valentine’s Day gift to New York City. Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.
“There is no better backdrop than the Empire State Building’s unparalleled views as you celebrate love this Valentine’s Day,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “We are excited to offer the exclusive opportunity for one couple to have our iconic Observatory all to themselves in New York City’s most romantic date.”
The Empire State Building Observatory Experience recently underwent a $165 million reimagination that features an interactive museum with nine galleries, brand-new bespoke Observatory host uniforms, and iconic Observatories on the 86th and 102nd Floors.
Hi-res imagery can be downloaded here. More information about the Empire State Building and tickets can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust, Inc.
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240130140269/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
